USP <1116> and Contamination

Similar documents
The Most Probable Number Method and Its Use in QC Microbiology

How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant

The Most Probable Number Method and Its Use in QC Microbiology

Environmental Monitoring of Aseptic Processing Areas - 2

Bioburden Contamination Control: A Holistic Overview

BIO & PHARMA ANALYTICAL TECHNIQUES

This compilation of the complex

IN THIS SECTION MICROBIOLOGY TESTING EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT. Bacterial Endotoxin (LAL) Testing

MICROBIOLOGICAL CULTURE MEDIA

Best Practice in Environmental Monitoring

Recent USP Updates May, 2013

á61ñ MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS: MICROBIAL ENUMERATION TESTS

Microbiological Consideration for Non-Sterile Pharmaceutical

The Microbiological Requirements of a Stability Study. Ngoc Anh-Thu Phan 19 th June 2012

Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations Webinar Q&A

The International Harmonization of the Compendial Microbial Limits Tests A Cautionary Tale of Compendial Participation

Antimicrobial effectiveness evaluation of Isocide powder coating versus stainless steel plate

Today s Topics. General Quality Control Best Practices. Practices Antimicrobial Effectiveness Testing(AET) Best Practices Environmental Isolates

3.3.1 Microbial enumeration tests


Managing Your Environmental Isolates

UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS

Guidance for Industry

Published Standards ISO General instructions for microbiological examination ISO Enumeration and detection of aerobic mesophilic bacteri

Overview of a sterility assurance program for PET drugs

ANALYTICAL REPORT: Comparison of the Microbial Recovery Efficacy of QI Medical EnviroTest Paddles versus a Conventional Contact Plate

Final text for addition to The International Pharmacopoeia

Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans. Jim Klein and Geert Verdonk Merck & Co., Inc.

Disinfectant Qualification A Multifaceted Study

The Parenteral Drug Association

Compounding Pharmacies and the USP <71> Sterility Tests

Managing Your Environmental Isolates

Environmental Monitoring of Aseptic Processing Areas - 1

FDA s Guidance for Industry

Tests to Support Sterility Claim. Imtiaz Ahmed

ISO INTERNATIONAL STANDARD

GUIDE TO INSPECTIONS OF MICROBIOLOGICAL PHARMACEUTICAL QUALITY CONTROL LABORATORIES

Microbiological Quality Control as Described in the Compendia. Scott Sutton, Ph.D.

Method Suitability Report Membrane Filtration Sterility Test with QTMicro Apparatus

Microbiology Method Variability and Sensitivity in the Detection of Total

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Julie Roberts. Audit hot Topics and Regulatory Requirements

Introduction. Michael J. Miller, Ph.D. RMM»

Study Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.

Biocontamination control in pharmaceutical production

Analytical Service Code

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Disinfection Qualification Testing

Working document QAS/ June 2011 RESTRICTED DRAFT FOR COMMENT

DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT

EXAMPLES OF WHAT PLATES LOOK LIKE

Working document QAS/11.415/Rev. 1 August 2011 RESTRICTED DRAFT FOR COMMENT

Avoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS

Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products

COUNT METHOD 5.0 OBJECTIVES 5.1 INTRODUCTION 5.2 PRINCIPLE. Structure

Current Industry Trends -Including Cleaning and Disinfection trends, Disinfectant Validation Trends, and Current Warning Letter Activity.

Microbiological Cleaning Method Validation

70% Isopropyl Alcohol

Industry Perspective on PET Manufacturing Comparison of EU and US

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

[PPT PDF] Pharmaceutical Water System Design Validation - Microbial Testing of Water is discussed in detail in this article.

Specifications, Methods and precedence of source with particular reference to microbiological requirements in TGOs.

A risk based approach to managing environmental excursions

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR HEALTH SUPPLEMENTS

Growth Promotion Test Guide for Media Used in Sterility Tests

Rapid Microbiological Methods: Why and what!

The ABCs and Challenges of GMP The American Experience

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

STS Directory Accreditation number: STS 0268

Bacterial Counts - Quantitative Analysis of Microbes

USP Chapter <797> & <800> Testing Supplies

ANNEX 1: COMMENT SUBMISSION DOCUMENT

Complaints Investigations Root Cause Analysis

GUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION

Robert Westney, M.S., RAC, CMQ/OE Director of Quality and Operations Cryologics, Inc. March 7, 2017

Qualification of an Environmental Monitoring Program

Rapid Microbiological. PDA: A Global. Methods. Association. Gilberto Dalmaso Aseptic Processes Development Manager

TECHNICAL LEAFLET. MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S)

BIMM 121 Letter Grade by Practicum. Student Information Sheet

Biocidal Surface Test - Clinell Wipes ~ Project Report Prepared for GAMA Healthcare Ltd ~ Huddersfield Microbiology Services Oct 06

Raad voor Accreditatie (Dutch Accreditation Council RvA) Explanatory document on microbiology

FINAL REPORT LOW LEVEL DISINFECTION EVALUATION VIOGUARD KEYBOARD

Metrics in Microbiology Monitoring Practices

STANDARD OPERATING PROCEDURE FOR MICROBIOLOGICAL EXAMINATION OF CARCASSES BY WET/DRY SWABBING

Serial dilution and colony count (Viable count) Pour plate. Spread plate Membrane filtration. Turbidity. Microscopic cell count

FINAL REPORT LOW LEVEL DISINFECTION EVALUATION VIOGUARD KEYBOARD

CERTIFICATE OF ACCREDITATION

Microbiological Quality of Drug Products after Penetration of the Container System for Dose Preparation Prior to Patient Administration

for IND and RDRC Regulated PET Compounding

CERTIFICATE OF ACCREDITATION

Determination of Inoculum for Microbiological Testing

Microbiology for Oral and Topical Products - The basics Scott Colbourne Business Manager NSW ALS Food & Pharmaceutical

ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs

Principles of Preservation

LUNCH AND LEARN. September 11, CE Activity Information & Accreditation

MICROBIAL LIMIT TESTS FOR RAW MATERIALS AND NON-STERILE PRODUCTS REVIEW-DISCUSSIONS-INTERPRETATIONS

~/oj 3i. Qualification Qualification of analytical instrumentation is essential for accurate and precise measurement of analytical data.

Swab and Samplers Test Kits Quality control as easy as 1, 2, 3

Transcription:

USP <1116> and Contamination Recovery Rates Scott Sutton ABSTRACT United States Pharmacopeia (USP) <1116> "Microbiological Control and Monitoring of Aseptic Processing Environments" approaches analysis of environmental monitoring (EM) data in the aseptic core from a perspective of "contamination recovery rates" while noting a need to improve EM data analysis. There are two difficulties in using EM data from the aseptic core: Most of the plate counts should be "zero" The actual numerical plate counts seen are far below the limit of quantification (LOQ) for the plate count method. USP <1116> suggests using "percent contamination recovery rate" as the measure, but other options are available: The use of quality control ( QC) control charts has been suggested for these data The use of most probable number (MPN) analysis has been suggested for analysis of these data-this may be a more appropriate method given the Poisson distribution of the data and its very low numbers. Limitations of this approach should also be considered; some tracking of magnitude of excursions as well as trending of microorganism identity throughout the facility is needed. INTRODUCTION The United States Pharmacopeia (USP) <1116> "Microbiological Control and Monitoring of Aseptic Processing Environments" (1) marks a significant shift in regulatory thinking regarding microbiological monitoring of aseptic areas. This shift leads away from arbitrary numerical levels in these extremely clean environments to a more qualitative trending methodology. In addition to the important information in this chapter on new ways to set alert and action levels for environmental monitoring (EM) programs, this chapter also stresses the separate and important task of controlling these environments. The following outlines this chapter: Introduction Clean Room Classification for Aseptic Processing Environments Importance of a Microbiological Evaluation Program for Controlled Environments Physical Evaluation of Contamination Control Effectiveness Training or Personnel Critical Factors in the Design and Implementation of a Microbiological Environmental Monitoring Program Selection of Growth Media Selection of Culture Conditions Establishment of Sampling Plan and Sites Selection of Sample Sites Within Clean Rooms and Aseptic Processing Areas Microbiological Control Parameters in Clean Rooms, Isolators, and RABS Significant Excursions Further Considerations About Data Interpretation Sampling Airborne Microorganisms Surface Sampling Culture Media and Diluents For more Author in1orma\ion, go to gxpandjvt.com/bios ABOUT THE AUTHOR Scott Sutton, Ph.D., is the founder and principal consultant of Microbiology Network, Inc (http://bit.ly/ n62yfg). He is a recognized consultant and trainer with emphasis in GMP, investigations, environmental monitoring, and contamination control as well as microbiology laboratory audits and operations. He may be reached by e-mail at scott.sutton@microbiol.org. gxpandjvt.com ]OURNAL OF VALIDATION TECHNOLOGY (AUTUMN 2012) 79

Identification of Microbial Isolates Conclusion Appendix/Glossary. USP <1116> MICROBIOLOGICAL CON TROL AND MONITORING OF ASEPTIC PROCESSING ENVIRONMENTS The concern about reliable alert and action levels for the aseptic core hinge on two considerations: The limit of quantification for the plate count method The prevalence of "zero" in the data set. This paper will first look at the issues in the limit of quantification. LIMIT OF DETECTION VERSUS LIMIT OF QUANTIFICATION The general ranges in common acceptance for countable numbers of colonies on a plate are 30-300 or 25-250 colony forming units (cfu). Breed and Dotterrer noted that, "the kind of bacteria in the material under examination will have an influence on the size of the colonies, and consequently, on the number that can develop on a plate." They also noted that food supply can be an issue, that colonies close to each other on the plate may merge, and that neighbor colonies may inhibit growth or conversely stimulate growth. "Because of these and other difficulties certain plates in any series made from a given sample are more satisfactory for use in computing a total than are others. The matter of selecting plates to be used in computing a count becomes therefore a matter requiring considerable judgment (2)." This study determined that plates with more than 400 cfu were unsatisfactory, as were those of less than 30 cfu, with best results in the range of 50-200 cfujplate (2). From this study originated the 30-300 rule for the "countable" range of colonies on a plate. Tomasiewicz et al reevaluated the question of countable range on a plate, again taking data from colony counts of raw milk. This study used data from three different experiments (each dilution plated in triplicate) to determine a mean-squared-error of the estimate for all plates. Their recommendation, at the end of the study, was for a countable range of 25-250 cfujplate in triplicate. This study is also notable for excellent cautionary advice. 80 ]OURNAL OF VALIDATION TECHNOLOGY (AUTUMN 2012) "The data presented herein are not necessarily applicable to other systems. For automated equipment, the optimum range may well vary with the instrument... Furthermore, even if automation is not used appropriate numbers of colonies that should be on a countable plate can very widely, depending on many other variables. With soil fungi for example... (3)" USP has recently harmonized a microbial enumeration test (4). This test recommends, "Select the plates corresponding to a given dilution and showing the highest number of colonies less than 250 for [total, aerobic microbial count] TAMC and 50 for [total combined yeast and mold] TYMC. In determination of the resistance of biological indicators, USP recommends a range of "20 to 300 colonies, but not less than 6 (5)." However, the most complete description of the countable range is found in the informational chapter <1227> (6). "The accepted range for countable colonies on a standard agar plate is between 25 and 250 for most bacteria and Candida albicans. This range was established in the food industry for counting coliform bacteria in milk. The range is acceptable for compendia! organisms, except for fungi. It is not optimal for counting all environmental monitoring isolates. The recommended range for Aspergillus niger is between 8 to 80 cfu per plate. The use of membrane filtration to recover challenge organisms, or the use of environmental isolates as challenge organisms in the antimicrobial effectiveness testing, requires validation of the countable range (6)." ASTM provides countable ranges of 20-80 cfujmembrane, 20-200 for spread plates, and 30-300 for pour plates (7). The US Food and Drug Administration's Bacterial Analytical Manual (BAM) recommends 25-250 cfujplate as a countable range (8). The general consensus of these documents is that, at best, the limit of quantification (LOQ) for the plate count method is no less than 20 cfujplate. This leads to direct problems with the currently accepted regulatory levels that are set near the limit of detection (1 cfujplate) rather than the LOQ (9). CONTAMINATION RECOVERY RATES VERSUS NUMERICAL LEVELS Contamination recovery rates in USP <1116> are defined as the percentage of plates that show any microbial recovery irrespective of number of cfu. This term is defined in the glossary of USP <1116>. ivtnetwork.com

SCOTT SUTTON Table: Suggested initi~l ~ontamination recovery rates in_ aseptic ~nvironments. Room Classification Isolator/Closed RABS {ISO 5 or better) -.j. Active Air Settle Plate (9 em) Contact Plate Glove or Sample (%) - - 4 hr exposure (%) or Swab (%) Garment (%) <0.1 <0.1 <0.1 <0.1 --!----- ------ IS05 <1 <1 <1 <1 IS06 ISO? ---~---- - ~ I <3 <3 <3 <3 - ---- <5 <5 <5 <5 ISO 8 <10 <10 <10 <10 This table is reproduced from Table 3 of USP <1116> (1) "The contamination recovery rate is the rate at which environmental samples are found to contain any level of contamination. For example, and incident rate of 1% would mean that only 1% of the samples taken have any contamination regardless of colony number." The alert and action levels are then defined relative to these percentages. The user is encouraged to collect data and set these averages for the specific facility and sample site (see Table for suggested contamination rates). This is in sharp contrast to currently accepted levels of contamination listed in the 2004 FDA guidance (10) as well as other guidance documents where, in a grade B (class 1000, International Organization for Standardization [ISO] cleanroom six), great significance is placed on a result of 6 cfu versus 7 cfu (pass/ fail) in active air monitoring or 2 cfu versus 3 cfu in settling plates. All of these numbers are well within the noise level of the plate count method. Note, the FDA Aseptic Processing Guide is used only for illustrative purposes without any intention of singling this document out for special mention. All current regulatory guidance in aseptic processing from Europe and the United States, as well as trade industry technical reports, repeat these, or very similar, action levels. This break with accepted dogma may be the single greatest contribution of this chapter revision. WHY THE MAJOR CHANGE IN FOCUS? The problem with looking at numerical limits for microbiological tests is that the levels have to be reasonable in terms of the capability of the method. USP <1227> (1) relies heavily on the established scientific literature in its discussion of this range of countable colonies on a plate (2, 3) to note that colonies have a lower LOQ of approximately 25 colonies per plate. This is opposed to the limit of detection of one colony gxpandjvt.com per plate. EM alert and action levels in the 1-10 cfu range are therefore of questionable accuracy. There is a real need for better quality tools, and this need has led to the shift to contamination recovery rates rather than arbitrary cfu numbers as proposed levels. This chapter is now official (1), and these contamination recovery rates appear in tables of suggested levels for different classes. The table on suggested initial contamination recovery rates in aseptic environments (reproduced above) suggests initial rates (percent contamination-nonzero-samples) in different areas. The obvious method of implementation for these rates is on a rolling average, but it is left to the operator to determine the appropriate interval for this average. In addition to the contamination recovery percentage, the role of "significant excursions" (i.e., excursions of approximately 15 cfu on a plate) is discussed. The chapter provides a good discussion of how to evaluate these events for significance, a general input on methodology, and a glossary of terms. While there may be some difficulty with using this particular measure (contamination recovery rates) as a trending tool (see discussion below on EM data as normally distributed or in a Poisson distribution), the great contribution of this chapter has to be the recognition that current EM criteria in the aseptic core is completely arbitrary and contrary to good science. Making critical decisions on the state of control of a facility based on numbers well into the noise range of the assay is unwise. A different method of analysis for these data should be developed, and USP <1116> describes one such method; it is the first regulatory document to address this question from a valid estimation of the plate count method's capabilities. In addition, this analysis fits in well with the FDA recommendation that, "Increased incidence of contamination over a given period is an equal or more significant trend to be tracked (10)." ]OURNAL OF VALIDATION TECHNOLOGY (AUTUMN 2012) 81

PEER REVIEWED: MICROBIOLOGY There are other recommendations in the literature on how to address EM data from aseptic core areas where the predominant result will be "zero cfu." In specifically considering environmental monitoring data, one can look at two publications in the recent decade. OTHER METHODS OF TRENDING "NON-ZEROES" Caputo and Huffman Caputo and Huffman propose two methods to trend EM data from highly aseptic areas. Like USP <1116> they note that most data are "zero" from these areas, and this makes any type of data analysis difficult. They also stress that, in many cases, the magnitude of an individual excursion is less informative than the frequency with which contamination occurs. Both of the methods proposed use well-known quality control (QC) graphing techniques, the individual value/ moving range (1-MR) control chart, and the exponentially weighted moving average (EWMA) control chart. To test their proposed methods, Caputo and Huffman generated a normally distributed data set of values around 10-day (n=100) and eight-day intervals (n=85) intervals of "non-zero" readings. As both of the graphing methods are appropriate for normally distributed data, both methods worked admirably with this data set. This study is noteworthy as it is the first formal treatment of the use of contamination rate (e.g., the frequency of "non-zero" readings) to trend EM data. In this, it is a great step forward beyond the use of arbitrary numbers located deep in the noise range of the plate count method (11). The difficulty with this method is that, while it is admirably suited for used with data that follow a "normal" distribution, it may not be appropriate for data that follow a Poisson distribution (such as EM data) (12). A more appropriate model might be that recommended by Sun et al (13). Sun et al Sun's group described the use of most probable number (MPN) technology for trending bacterial counts in EM data. Their discussion begins with an excellent introduction to the MPN method with specific emphasis on the Halverson and Ziegler equation (14); this forms the basis for their data analysis. From this base, they develop a compelling argument for the use of this MPN method: It is appropriate for data following a Poisson distribution. It is computationally straightforward. 82 ]OURNAL OF VALIDATION TECHNOLOGY [AUTUMN 2012] It yields numerical estimates more accurate (and more sensitive) than averaging when the contamination rate is <0.2%. It allows trending of "numerical" data. They tested this method using data generated from two main areas. EM data from an aseptic manufacturing suite (grade B) that included active air monitoring data and surface (floor) samples; EM data from a laminar flow hood in a test lab that was collected passive monitoring (settle plates) collected. All data sets met the chi-squared test for goodness-of-fit with a Poisson distribution. The method is used,"... to analyze the trend of the environmental monitoring data. The raw... are grouped choosing the minimum total sampling number n, and at least including one positive sample. This calculation will result a maximum MPN when a positive count is observed, thus increasing the sensitivity of the monitoring (12)." The MPN equation used here is: MPN = 2.303*1og<,o> Total.i~.Group Zeroes.m.Group Or, the MPN estimate is equal to 2.303 times the log 10 value of the ratio of the total number of readings in the group divided by the number of readings in the group of no recovery. Now, while this method is described in the text as a method to trend by dates, this can also be used to trend by operators, locations, and other factors. Other Trending Requirements in Aseptic Core It is important to remember that this method is restricted to trending and alert/action levels for "quantitative" EM only. While it will admirably suit FDA expectations for trending of" data generated by location, shift, room, operator, or other parameters (10)," it will not meet expectations for trending programs of microorganisms by identity or by characteristic (e.g., tending spore forming microorganisms as a check on the sanitization program). In addition, as pointed out in USP <1116>, it is also important to track and trend significant excursions as part of the EM program. CONCLUSIONS The common regulatory method of setting microbiological alert and action levels for the environmental monitoring program is not scientifically defensible as the arbitrary levels are set well within the noise level of the plate count assay. The recent revision of USP <1116> "Microbiological Control and Monitoring of Aseptic Processing Environments" addresses this with ivtnetwork.com

SCOTT SUTTON the strong recommendation that these questionable levels be replaced by trending "zero" and "non-zero" in these cases. The trending tool recommended is the use of "recovery frequency" measures. Two other methods of analysis are discussed in this review that might be useful in trending data from the aseptic core and in qualifying the alert and action levels. One method uses QC charts (11) and the other a variant of the MPN method (13). The MPN method was validated using actual EM data, and it would be this paper's recommendation for a useful method of qualifying alert and action levels and trending microbiological EM data in the aseptic core. REFERENCES 1. USP, "USP <1116> Microbiological Control and Monitoring of Aseptic Processing Environments," USP 35 1, United States Pharmacopeia! Convention, 697-707, 2012. 2. R. Breed and W.O. Dotterrer, "The Number of Colonies Allowable On Satisfactory Agar Plates," Journal of Bacteriolology l, 321-331, 1916. 3. D.M. Tomasiewicz et al, "The Most Suitable Number of Colonies On Plates for Counting," Journal of Food Protection 43 (4), 282-286, 1980. 4. USP, "USP <61> Microbial Examination of Nonsterile Products: Microbial Enumeration Tests," USP 35 1, United States Pharmacopeia! Convention, 56-60, 2012b. 5. USP, "USP <55> Biological Indicators- Resistance Performance Tests," USP 35 1, United States Pharmacopeia! Convention, 54-56, 2012c. 6. USP, "USP <1227> Validation of Microbial Recovery from Pharmacopeia! Articles," USP 35 1, United States Pharmacopeia! Convention, 883-885, 2012d. 7. ASTM, "05465-93 (1998)," Standard Practice for Determining Microbial Colony Counts from Waters Analyzed by Plating Methods, 1998. 8. L.J. Maturin and J.T. Peeler. "Aerobic Plate Count," in Bacteriological Analytical Manual (FDA, Rockville, MD, Nov. 10, 2012) available at: http://www.fda.gov/food/ ScienceResearch/LaboratoryMethods/BacteriologicalAnalyticalManualBAM/ucm063346.htm. 9. S. Sutton, "The Environmental Monitoring Program In a GMP Environment," Journal of GXP Compliance 14 (3), 22-30, 2010. 10. FDA, Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing - Current Good Manufacturing Practice (Rockville, MD, Sept. 2004). 11. R.A. Caputo and A. Huffman, "Environmental Monitoring: Data Trending Using a Frequency Model," PDA Journal of Pharmaceutical Science Technology 58 (5), 254-260, 2004. 12. J. Wilson, "Setting Alert/Action Limits for Environmental Monitoring Programs," PDAJournal of Pharmaceutical Science Technology 51 (4), 161-162, 1997. 13. X. Sun et al, "The Expanded Application of Most Probable Number to the Quantitative Evaluation of Extremely Low Microbial Count," PDA Journal of Pharmaceutical Science Technology 60 (2), 124-134, 2006. 14. H.O. Halvorson and N.R. Ziegler, "Application of Statistics to Problems In Bacteriology: II A Consideration of the Accuracy of Dilution Data Using a Single Dilution," Journal of Bacteriolology 26 (4), 331-339, 1933. GENERAL REFERENCES PDA, "PDA Comments On USP In-Process Revision <1116> Microbiological Evaluation of Clean Rooms and Other Controlled Environments," PDA Journal of Pharmaceutical Science Technology 49 (6), 264-266, 1995. JVT gxpandjvt.com /OURNAL OF VALIDATION TECHNOLOGY (AUTUMN 2012] 83